Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Mem. Inst. Oswaldo Cruz ; 105(4): 587-597, July 2010. tab, ilus
Artigo em Inglês | LILACS | ID: lil-554834

RESUMO

The objective of the present paper was to compare accessibility and utilisation of schistosomiasis diagnostic and treatment services in a small village and the surrounding rural area in northern part of the state of Minas Gerais Brazil. The study included 1,228 individuals: 935 central village residents and 293 rural residents of São Pedro do Jequitinhonha. Schistosoma mansoni infection rates were significantly higher in the central village than in the rural area during a survey in 2007 (44.3 percent and 23.5 percent, respectively) and during the 2002 schistosomiasis case-finding campaign (33.1 percent and 26.5 percent, respectively) (p < 0.001). However, during the 2002-2006 period, only 23.7 percent of the villagers and 27 percent of the rural residents obtained tests on their own from health centres, hospitals and private clinics in various nearby towns. In 2007, 63 percent of the villagers and 70.5 percent of the rural residents reported never having received treatment for schistosomiasis. This paper reveals considerable variation in the accessibility and utilisation of schistosomiasis-related health services between the central village and the rural area. A combination of low utilisation rates between 2002-2006 and persistently high S. mansoni infection rates suggest that the schistosomiasis control program must be more rapidly incorporated into the primary health services.


Assuntos
Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Adulto Jovem , Pesquisas sobre Atenção à Saúde , Acessibilidade aos Serviços de Saúde/estatística & dados numéricos , Atenção Primária à Saúde , Esquistossomose mansoni , Brasil , Prevalência , População Rural , Fatores Socioeconômicos , Esquistossomose mansoni , Esquistossomose mansoni , Esquistossomose mansoni , Esquistossomicidas
2.
Mem. Inst. Oswaldo Cruz ; 101(supl.1): 299-306, Oct. 2006. graf
Artigo em Inglês | LILACS | ID: lil-441263

RESUMO

Urinary schistosomiasis remains a significant burden for Africa and the Middle East. The success of population-based control programs will depend on their impact, over many years, on Schistosoma haematobium reinfection and associated disease. In a multi-year (1984-1992) control program in Kenya, we examined risk for S. haematobium reinfection and late disease during and after annual school-based treatment. In this setting, long-term risk of new infection was independently associated with location, age, hematuria, and incomplete treatment, but not with sex or frequency of water contact. Thus, very local environmental features and age-related factors played an important role in S. haematobium transmission, such that population-based control programs should optimally tailor their efforts to local conditions on a village-by-village basis. In 2001-2002, the late benefits of earlier participation in school-based antischistosomal therapy were estimated in a cohort of formerly-treated adult residents compared to never-treated adults from the same villages. Among age-matched subjects, current infection prevalence was lower among those who had received remote therapy. In addition, prevalence of bladder abnormality was lower in the treated group, who were free of severe bladder disease. Treatment of affected adults resulted in rapid resolution of infection and any detectable bladder abnormalities. We conclude that continued treatment into adulthood, as well as efforts at long-term prevention of infection (transmission control) are necessary to achieve optimal morbidity control in affected communities.


Assuntos
Adolescente , Animais , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Serviços de Saúde Escolar , Esquistossomose Urinária/tratamento farmacológico , Esquistossomicidas/uso terapêutico , Quênia/epidemiologia , Prevalência , Fatores de Risco , Esquistossomose Urinária/epidemiologia , Esquistossomose Urinária/prevenção & controle
3.
Mem. Inst. Oswaldo Cruz ; 97(suppl.1): 149-152, Oct. 2002. ilus, graf
Artigo em Inglês | LILACS | ID: lil-325007

RESUMO

A major advance in our understanding of the natural history of Schistosoma haematobium-related morbidity has come through the introduction of the portable ultrasound machines for non-invasive examination of the kidneys and bladder. With the use of generators or battery packs to supply power in non-clinical field settings, and with the use of instant photography or miniaturized thermal printers to record permanent images, it is possible to examine scores of individuals in endemic communities every day. Broad-based ultrasound screening has allowed better definition of age-specific disease risks in urinary schistosomiasis. Results indicate that urinary tract abnormalities are common (18 percent overall prevalence) in S. haematobium transmission areas, with a 2-4 percent risk of either severe bladder abnormality or advanced ureteral obstruction. In longitudinal surveys, ultrasound studies have shown that praziquantel and metrifonate therapy are rapidly effective in reversing urinary tract abnormalities among children. The benefits of treating adults are less well known, but research in progress should help to define this issue. Similarly, the prognosis of specific ultrasound findings needs to be clarified, and the ease of sonographic examination will make such long-term follow-up studies feasible. In summary, the painless, quick, and reproducible ultrasound examination has become an essential tool in the study of urinary schistosomiasis


Assuntos
Animais , Humanos , Criança , Adulto , Adolescente , Esquistossomose Urinária , Doenças Urológicas , Estudos Transversais , Quênia , Estudos Longitudinais , Contagem de Ovos de Parasitas , Prevalência , Esquistossomose Urinária , Sistema Urinário , Doenças Urológicas
4.
Mem. Inst. Oswaldo Cruz ; 87(supl.4): 203-10, 1992. ilus
Artigo em Inglês | LILACS | ID: lil-125651

RESUMO

Severity of urinary tract morbidity increases with intensity and duration of Schistosoma haematobium infection. We assessed the ability of yearly drug therapy to control infection intensity and reduce S. haematobium-associated disease in children 5-21 years old in an endemic area of Kenya. In year I, therapy resulted in reduced prevalence (66% to 22%, P < 0.001) and intensity of S. haematobium infection (20 to 2 eggs/10 mL, urine), with corresponding reductions in the prevalence of hematuria (52% to 19%, P < 0.001). There was not, however, a significant first-year effect on prevalence of urinary tract abnormalities detected by ultrasound. Repeat therapy in years 2 and 3 resulted in significant regression of hydronephrosis and bladder abnormalities (41% to 6% prevalence, P< 0.001), and further reductions in proteinuria. Repeat age-targeted therapy was associated with decreased prevalence of infection among young children (< 5yr) entering into the target age group. Two years after discontinuation of therapy, intensity of S. haematobium infection and ultrasound abnormalities remained suppressed, but hematuria prevalence began to increase (to 33% in 1989). Reinstitution of annual therapy in 1989 and 1990 reversed this trends. We conclude that annual oral therapy provides an effective strategy for control of morbidity due to S. haematobium on population basis, both through regression of disease in treated individuals, and prevention of infection in untreated subjects


Assuntos
Praziquantel/uso terapêutico , Esquistossomose Urinária/prevenção & controle , Triclorfon/uso terapêutico , Quênia , Esquistossomose Urinária/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA